Patents Assigned to IMARKO RESEARCH S.A.
  • Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
    Patent number: 9375461
    Abstract: The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The invention also has as an object such a composition for use as a drug, cosmetic agent, medical device, dietary composition, dietary supplement or nutraceutical, notably for use in preventing or treating obesity, atherosclerosis, type 2 diabetes or for use in preventing or reducing excess weight.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: June 28, 2016
    Assignee: IMARKO RESEARCH S.A.
    Inventor: Max Rombi
  • FATTY ACID DERIVATIVES FOR TREATING INFECTIOUS DISEASES
    Publication number: 20150258057
    Abstract: The present invention relates to a fatty acid metal salt, where said fatty acid comprises 6 to 12 carbon atoms, said salt being a copper salt or a zinc salt, and compositions comprising same, for use in altering the lipid bilayer of cell membranes, and in particular for use as a medicine, as a cosmetic agent, as a medical device, as a food composition, as a nutraceutical or a food supplement.
    Type: Application
    Filed: March 13, 2015
    Publication date: September 17, 2015
    Applicant: IMARKO RESEARCH S.A.
    Inventor: Max ROMBI
  • COMPOSITION COMPRISING A COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME, FOR USE IN PREVENTING TRIGLYCERIDE SYNTHESIS
    Publication number: 20130323219
    Abstract: The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The invention also has as an object such a composition for use as a drug, cosmetic agent, medical device, dietary composition, dietary supplement or nutraceutical, notably for use in preventing or treating obesity, atherosclerosis, type 2 diabetes or for use in preventing or reducing excess weight.
    Type: Application
    Filed: May 22, 2013
    Publication date: December 5, 2013
    Applicant: Imarko Research S.A.
    Inventor: Max ROMBI
  • COMPOSITION COMPRISING A COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME, FOR USE IN PREVENTING TRIGLYCERIDE SYNTHESIS
    Publication number: 20130216518
    Abstract: The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The invention also has as an object such a composition for use as a drug, cosmetic agent, medical device, dietary composition, dietary supplement or nutraceutical, notably for use in preventing or treating obesity, atherosclerosis, type 2 diabetes or for use in preventing or reducing excess weight.
    Type: Application
    Filed: October 28, 2011
    Publication date: August 22, 2013
    Applicant: IMARKO RESEARCH S.A.
    Inventor: Max Rombi